2024 annual financial data
Recursion Pharmaceuticals 2024 Operating margin
Recursion Pharmaceuticals 2024 operating margin with verified reported values.
Direct answer
Operating margin was -814.09%.
Operating income was -479,004,000 USD and net income was -463,661,000 USD.
Operating cash flow was -359,174,000 USD.
Get free Recursion Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 58,839,000 USD
- Operating income
- -479,004,000 USD
- Net income
- -463,661,000 USD
- Operating cash flow
- -359,174,000 USD